Erschienen in:
02.01.2019 | Original Article
Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy
verfasst von:
Zaid Bilgrami, Ameer Abutaleb, Kenechukwu Chudy-Onwugaje, Patricia Langenberg, Miguel Regueiro, David A. Schwartz, J. Kathleen Tracy, Leyla Ghazi, Seema A. Patil, Sandra M. Quezada, Katharine M. Russman, Charlene C. Quinn, Guruprasad Jambaulikar, Dawn B. Beaulieu, Sara Horst, Raymond K. Cross Jr.
Erschienen in:
Digestive Diseases and Sciences
|
Ausgabe 1/2020
Einloggen, um Zugang zu erhalten
Abstract
Introduction
Limitations in inflammatory bowel disease (IBD) care necessitate greater patient activation and self-efficacy, measures associated with positive health outcomes.
Methods
We assessed change in patient activation and general self-efficacy from baseline to 12 months through our TELEmedicine for IBD trial, a multicenter, randomized controlled trial consisting of a web-based monitoring system that interacts with participants via text messaging. A total of 222 adults with IBD who had experienced an IBD flare within 2 years prior to the trial were randomized into either a control arm that received standard care (SC) or an intervention arm that completed self-testing through the TELE-IBD system every other week (EOW) or weekly (W).
Results
Changes in self-efficacy scores were not significantly different between control and experimental groups. Patient activation scores were significantly different between standard care and the TELE-IBD EOW group only (p = 0.03).
Conclusions
Use of remote monitoring did not improve self-efficacy or patient activation compared to routine care.